Table 2.
Demographic properties of the babies
| Group 1 FA (−) (n= 12) | Group 2 (25 μg/g) (n=46) | Group 3 (50 μg/g) (n=39) | Group 4 (75 μg/g) (n=44) | General | |
|---|---|---|---|---|---|
| Gender (M/F) n (% ) | 8 (66.7)/4 (33.3) | 22 (47.8)/24 (52) | 16 (41)/23 (59) | 20 (45.5)/24 (54.5) | 66 (46.8)/75 (53.2) |
| p | 0.480 | ||||
| SGA n (%) | 6 (50) | 18 (39.1) | 18 (46.2) | 22 (50) | 64 (45.3) |
| p | 0.749 | ||||
| Exclusively breasfed n (%) | 0 (0) | 6 (13) | 7 (18.4) | 2 (4.8) | 15 (10.6) |
| p | 0.132 | ||||
| FA intake during pregnancy n (%) | 11 (91.7) | 40 (87) | 34 (87.2) | 40 (90.9) | 125 (88.6) |
| p | 0.909 | ||||
| Pre-eclampsia n (%) | 4 (33.3) | 18 (39.1) | 11 (28.2) | 13 (29.5) | 46 (32.6) |
| p | 0.814 | ||||
| TPN n (%) | 9 (75) | 27 (58.7) | 21(53.8) | 31 (70.5) | 88 (62.4) |
| p | 0.319 | ||||
| Hospitalization for blood transfusion n (%) | 0 | 4 (8.7) | 0 | 2 (4.5) | 6 (4.3) |
| p | 0.638 |
FA: folic acid; F: female; M: male; RBCFL: red blood cell folate level; SGA: small-for-gestational age; TPA: total parenteral nutrition